SANGAMO THERAPEUTICS, INC. Variable Lease, Cost
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Variable Lease, Cost of $3.17 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-30
- SANGAMO THERAPEUTICS, INC. variable lease, cost for the quarter ending 2021-06-30 was $614.00K, a 11.23% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. variable lease, cost for the quarter ending 2021-03-31 was $700.00K, a 40.00% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. variable lease, cost for the quarter ending 2020-12-31 was $700.00K, a 0.00% change year-over-year.
- SANGAMO THERAPEUTICS, INC. variable lease, cost for the quarter ending 2020-09-30 was $1.00M, a 66.67% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. variable lease, cost for fiscal 2025 was $3.17M, a 10.55% decline from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. variable lease, cost for fiscal 2024 was $3.54M, a 13.37% increase from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. variable lease, cost for fiscal 2023 was $3.13M, a 5.42% decline from fiscal 2022.
- SANGAMO THERAPEUTICS, INC. variable lease, cost for fiscal 2022 was $3.31M, a 16.74% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3.17M 10-K · filed 2026-03-30 | |||||
| 2024-12-31 | $3.54M 10-K · filed 2026-03-30 | |||||
| 2023-12-31 | $3.13M 10-K · filed 2025-03-17 | |||||
| 2022-12-31 | $3.31M 10-K · filed 2024-03-13 | |||||
| 2021-12-31 | $2.83M 10-K · filed 2023-02-23 | |||||
| 2021-06-30 | $614.00K 10-Q · filed 2021-08-05 | $1.33M 10-Q · filed 2021-08-05 | $2.01M derived: sum of 3 quarters · filed 2022-02-24 | $3.01M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2021-03-31 | $700.00K 10-Q · filed 2021-05-04 | $1.40M derived: sum of 2 quarters · filed 2022-02-24 | $2.40M derived: sum of 3 quarters · filed 2022-02-24 | $2.95M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.70M derived: sum of 2 quarters · filed 2022-02-24 | $2.25M derived: sum of 3 quarters · filed 2022-02-24 | $2.30M 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-04 | $1.55M derived: sum of 2 quarters · filed 2021-08-05 | $1.60M 10-Q · filed 2020-11-04 | $2.75M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-06-30 | $552.00K 10-Q · filed 2021-08-05 | $500.00K 10-Q · filed 2020-08-05 | $1.01M 10-Q · filed 2021-08-05 | $1.00M 10-Q · filed 2020-08-05 | $1.75M derived: sum of 3 quarters · filed 2021-08-05 | $2.35M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $500.00K 10-Q · filed 2021-05-04 | $1.20M derived: sum of 2 quarters · filed 2021-05-04 | $1.80M derived: sum of 3 quarters · filed 2021-05-04 | $2.20M derived: sum of 4 quarters · filed 2021-05-04 | ||
| 2019-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.30M derived: sum of 2 quarters · filed 2020-02-28 | $1.70M derived: sum of 3 quarters · filed 2020-02-28 | $1.90M 10-K · filed 2020-02-28 | ||
| 2019-09-30 | $600.00K 10-Q · filed 2019-11-06 | $1.00M derived: sum of 2 quarters · filed 2019-11-06 | $1.20M 10-Q · filed 2019-11-06 | |||
| 2019-06-30 | $400.00K 10-Q · filed 2019-08-07 | $600.00K 10-Q · filed 2019-08-07 | ||||
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-08 |